Amgen (NASDAQ:AMGN) announced 450 job cuts for the second time this year

US drugmaker Amgen (NASDAQ:AMGN) said it would lay off about 450 further jobs, less than 2 percent of its workforce, citing drug price pressures, as well as the impact of high inflation. At the end of January, the company announced 300 layoffs.

Leave a Comment